SynthesisFuture oncology (London, England)2024

Sacituzumab govitecan vs. chemotherapy for metastatic breast cancer: a meta-analysis on safety outcomes.

Alessandro Rizzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.